ATLAB Pharma :: Home
Description
pulled from site's meta descriptionATLAB Pharma develops antibody-targeted radiotherapy for cancer treatment.
This is an automatically generated AboutUs page for atlab-pharma.com. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
Categories:
- AboutUs AutoGen
- atlab
- atlab pharma
- abiraterone
- zytiga
- docetaxel
- taxotere
- cabazitaxel
- jevtana
- alpharadin
- algeta
- dendreon
- enzalutamide
- cougar
- medivation
- karim fizazi
- fizazi
- sartor
- oliver sartor
- chris parker
- parker
- tagawa
- scott tagawa
- irt1
- nuclear medicine
- radiopharmaceuticals
- targeting
- crpc
- mcrpc
- antibody
- prostate
- cancer
- prostate cancer
- radioimmunotherapy
- RIT
- immunotherapy
- Phase III
- Phase-III
- Phase 3
- biotech
- biotechnology
- Lutetium
- Astate
- Astatine
- ATL101
- ATL-101
- ATL201
- ATL-201
- ATL301
- ATL-301
- efficacy
- survival benefit
- micrometastasis
- radioisotope
- J591
- beta
- alpha
- therapeutic
- scintigraphy
- 177-lu
- PSMA
- Prostate Specific Membrane Antigen
- irradiation
- radioantibody
- radio-antibody
- radioconjugate
- arc
- radiotherapy
- microscopic disease
- weill
- cornell
- weill cornell
- lu-j591
- prostate cancer trial
- jean-marc le doussal
- le doussal
- jean-fran